The place of some newer non-anaesthetic drugs in anaesthetic practice.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000494:pharmacology; D000700:Analgesics / Q000009:adverse effects / Q000494:pharmacology; D000758:Anesthesia; D000777:Anesthetics; D000932:Antiemetics / Q000009:adverse effects / Q000494:pharmacology; D004315:Doxapram / Q000009:adverse effects / Q000494:pharmacology; D004620:Embolism, Fat / Q000188:drug therapy; D006801:Humans; D009125:Muscle Relaxants, Central / Q000009:adverse effects / Q000494:pharmacology; D010455:Peptides / Q000627:therapeutic use; D012137:Respiratory System / Q000187:drug effects; D013268:Stimulation, Chemical
D000319:Adrenergic beta-Antagonists; D000700:Analgesics; D000777:Anesthetics; D000932:Antiemetics; D009125:Muscle Relaxants, Central; D010455:Peptides; D004315:Doxapram